Integrin αV/β8, the binding partner of GARP, is expressed on PDA tumor cells, suggesting that the mechanism for the release of latent TGF-β from GARP upon binding of integrin αV/β8 to GARP does exist (Fig. 6b). Here, LRRC32 is linked to neoplasm.